HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of N-methylformamide for advanced renal cell carcinoma.

AuthorsC N Sternberg, A Yagoda, H I Scher, P Hollander
JournalCancer treatment reports (Cancer Treat Rep) Vol. 70 Issue 5 Pg. 681-2 (May 1986) ISSN: 0361-5960 [Print] United States
PMID3708620 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Formamides
  • methylformamide
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Carcinoma, Renal Cell (drug therapy, secondary)
  • Chemical and Drug Induced Liver Injury
  • Drug Evaluation
  • Female
  • Formamides (adverse effects, therapeutic use)
  • Humans
  • Kidney Neoplasms (drug therapy)
  • Lung Neoplasms (secondary)
  • Male
  • Middle Aged
  • Nausea (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: